Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.79 | -7.87 |
| PEG Ratio (TTM) | 0.20 | 1.61 |
| P/S Ratio (TTM) | 2.60 | 2.23 |
| P/B Ratio (TTM) | 2.48 | 1.63 |
| P/FCF Ratio (TTM) | 5.83 | 10.15 |
| Price to 5YR AVG Earnings Ratio | 15.72 | 5.23 |
| Price to 5YR AVG FCF Ratio | -14.94 | 8.54 |
Profitability (80%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 10.73% | 6.96% |
| ROE (TTM) | 29.09% | 11.17% |
| Net Profit Margin (TTM) | 30.17% | 17.56% |
| ROIC 5YR AVG | 10.02% | 12.16% |
Growth (92%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 9.35% | 346.85% | 2,127.71% |
| Revenue | -0.18% | 139.51% | 106.26% |
| Net Income | 9.18% | 388.74% | 2,140.68% |
| Cash Flow | 443.61% | 374.71% | 284.94% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.48 | 1.73 |
| Quick Ratio (TTM) | 1.23 | 1.58 |
| D/E Ratio (TTM) | 1.55 | 0.67 |
| Interest Coverage (TTM) | 3.01 | 12.22 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 2.32 | 2.24 |
| LTL to 5YR AVG FCF | -8.77 | 3.16 |
| Shares Outstanding Growth 5YR AVG | 10.32% | 12.49% |